51
Views
0
CrossRef citations to date
0
Altmetric
Original Research

Performance of noninvasive prenatal screening for fetal sex chromosome aneuploidies in a cohort of 116,862 pregnancies

, , , , , , , , & ORCID Icon show all
Pages 467-472 | Received 29 Aug 2023, Accepted 20 Feb 2024, Published online: 25 Mar 2024

References

  • Allyse MA, Wick MJ. Noninvasive prenatal genetic screening using Cell-free DNA. JAMA. 2018;320(6):591–592. doi: 10.1001/jama.2018.9418
  • Tekesin I. Cell-free DNA testing in routine practice: characterisation of a cohort with positive results for trisomies, sex chromosome anomalies and microdeletions. Geburtshilfe Frauenheilkd. 2021;81(1):81–89. doi: 10.1055/a-1226-6538
  • Gil MM, Accurti V, Santacruz B, et al. Analysis of cell-free DNA in maternal blood in screening for aneuploidies: updated meta-analysis. Ultrasound Obstet Gynecol. 2017;50(3):302–314. doi: 10.1002/uog.17484
  • Rezaei M, Winter M, Zander-Fox D, et al. A reappraisal of circulating fetal cell noninvasive prenatal testing. Trends Biotechnol. 2019;37(6):632–644. doi: 10.1016/j.tibtech.2018.11.001
  • Petersen AK, Cheung SW, Smith JL, et al. Positive predictive value estimates for cell-free noninvasive prenatal screening from data of a large referral genetic diagnostic laboratory. Am J Obstet Gynecol. 2017;217(6):e691.1– e691.6. doi: 10.1016/j.ajog.2017.10.005
  • van der Meij KRM, Sistermans EA, Macville MVE, et al. TRIDENT-2: national implementation of genome-wide non-invasive prenatal testing as a first-tier screening test in the Netherlands. Am J Hum Genet. 2019;105(6):1091–1101. doi: 10.1016/j.ajhg.2019.10.005
  • Rose NC, Kaimal AJ, Dugoff L, et al. Screening for fetal chromosomal abnormalities ACOG practice bulletin summary, number 226. Obstet & Gynecol. 2020;136(4):E48–E69.
  • Gregg AR, Skotko BG, Benkendorf JL, et al. Noninvasive prenatal screening for fetal aneuploidy, 2016 update: a position statement of the American college of medical genetics and genomics. Genet Med. 2016;18(10):1056–65. doi: 10.1038/gim.2016.97
  • Gravholt CH, Andersen NH, Conway GS, et al. Clinical practice guidelines for the care of girls and women with turner syndrome: proceedings from the 2016 Cincinnati international turner syndrome meeting. Eur J Endocrinol. 2017;177(3):G1–G70. doi: 10.1530/EJE-17-0430
  • Deng C, Cheung SW, Liu H. Noninvasive prenatal screening for fetal sex chromosome aneuploidies. Expert Rev Mol Diagn. 2021;21(4):405–415. doi: 10.1080/14737159.2021.1911651
  • Leggett V, Jacobs P, Nation K, et al. Neurocognitive outcomes of individuals with a sex chromosome trisomy: XXX, XYY, or XXY: a systematic review. Dev Med Child Neurol. 2010;52(2):119–129. doi: 10.1111/j.1469-8749.2009.03545.x
  • Urbanus E, van Rijn S, Swaab H. A review of neurocognitive functioning of children with sex chromosome trisomies: identifying targets for early intervention. Clin Genet. 2020;97(1):156–167. doi: 10.1111/cge.13586
  • Sybert VP, McCauley E. Turner’s syndrome. N Engl J Med. 2004;351(12):1227–1238. doi: 10.1056/NEJMra030360
  • Stochholm K, Juul S, Gravholt CH. Mortality and incidence in women with 47,XXX and variants. Am J Med Genet A. 2010;152A(2):367–372. doi: 10.1002/ajmg.a.33214
  • Wang JC, Sahoo T, Schonberg S, et al. Discordant noninvasive prenatal testing and cytogenetic results: a study of 109 consecutive cases. Genet Med. 2015;17(3):234–6. doi: 10.1038/gim.2014.92
  • Badeau M, Lindsay C, Blais J, et al. Genomics-based non-invasive prenatal testing for detection of fetal chromosomal aneuploidy in pregnant women. Cochrane Database Syst Rev. 2017;2017(11):CD011767. doi: 10.1002/14651858.CD011767.pub2
  • Jiang FM, Ren JH, Chen F, et al. Noninvasive fetal trisomy (NIFTY) test: an advanced noninvasive prenatal diagnosis methodology for fetal autosomal and sex chromosomal aneuploidies. BMC Med Genomics. 2012;5(1):11. doi: 10.1186/1755-8794-5-57
  • Chen Y, Yu Q, Mao X, et al. Noninvasive prenatal testing for chromosome aneuploidies and subchromosomal microdeletions/microduplications in a cohort of 42,910 single pregnancies with different clinical features. Hum Genomics. 2019;13(1):60. doi: 10.1186/s40246-019-0250-2
  • Deng C, Zhu Q, Liu S, et al. Clinical application of noninvasive prenatal screening for sex chromosome aneuploidies in 50,301 pregnancies: initial experience in a Chinese hospital. Sci Rep. 2019;9(1):9. doi: 10.1038/s41598-019-44018-4
  • Drmanac R, Sparks AB, Callow MJ, et al. Human genome sequencing using unchained base reads on self-assembling DNA nanoarrays. Science. 2010;327(5961):78–81. doi: 10.1126/science.1181498
  • Chen M, Fu X-Y, Luo Y-Q, et al. Detection of fetal duplication 16p11.2q12.1 by next-generation sequencing of maternal plasma and invasive diagnosis. J Matern-Fetal Neonatal Med. 2019;32(1):38–45. doi: 10.1080/14767058.2017.1369947
  • Dungan JS, Klugman S, Darilek S, et al. Noninvasive prenatal screening (NIPS) for fetal chromosome abnormalities in a general-risk population: an evidence-based clinical guideline of the American college of medical genetics and genomics (ACMG). Genet Med. 2022;25(8):100874. doi: 10.1016/j.gim.2023.100874
  • Wang Y, Li S, Wang W, et al. Cell-free DNA screening for sex chromosome aneuploidies by non-invasive prenatal testing in maternal plasma. Mol Cytogenet. 2020;13(1):13(1. doi: 10.1186/s13039-020-0478-5
  • Lu X, Wang C, Sun Y, et al. Noninvasive prenatal testing for assessing foetal sex chromosome aneuploidy: a retrospective study of 45,773 cases. Mol Cytogenet. 2021;14(1):1–Article No.: 1. doi: 10.1186/s13039-020-00521-2
  • Bussolaro S, Raymond YC, Acreman ML, et al. The accuracy of prenatal cell-free DNA screening for sex chromosome abnormalities: a systematic review and meta-analysis. Am J Obstet Gynecol MFM. 2023;5(3):100844. doi: 10.1016/j.ajogmf.2022.100844
  • Shear MA, Swanson K, Garg R, et al. A systematic review and meta‐analysis of cell‐free DNA testing for detection of fetal sex chromosome aneuploidy. Prenat Diagn. 2023;43(2):133–143. doi: 10.1002/pd.6298
  • Bianchi DW. Cherchez la femme: maternal incidental findings can explain discordant prenatal cell-free DNA sequencing results. Genet Med. 2018;20(9):910–917. doi: 10.1038/gim.2017.219
  • Petersen AK, Cheung SW, Smith JL, et al. Positive predictive value estimates for cell-free noninvasive prenatal screening from data of a large referral genetic diagnostic laboratory. Am J Obstet Gynecol. 2017;217(6):e691 1–e691 6. doi: 10.1016/j.ajog.2017.10.005
  • Luo Y, Hu H, Zhang R, et al. An assessment of the analytical performance of non-invasive prenatal testing (NIPT) in detecting sex chromosome aneuploidies: 34,717-patient sample in a single prenatal diagnosis centre in China. J Gene Med 2021;23(9). doi: 10.1002/jgm.3362
  • Payer B. Developmental regulation of X-chromosome inactivation. Semin Cell Dev Biol. 2016;56:88–99. doi: 10.1016/j.semcdb.2016.04.014
  • McNamara CJ, Limone LA, Westover T, et al. Maternal source of false-positive fetal sex chromosome aneuploidy in noninvasive prenatal testing. Obstet & Gynecol. 2015;125(2):390–392. doi: 10.1097/AOG.0000000000000547
  • Snyder MW, Simmons LE, Kitzman JO, et al. Copy-number variation and false positive prenatal aneuploidy screening results. N Engl J Med. 2015;372(17):1639–45. doi: 10.1056/NEJMoa1408408
  • Bianchi DW, Chiu RWK. Sequencing of circulating cell-free DNA during pregnancy. N Engl J Med. 2018;379(5):464–473. doi: 10.1056/NEJMra1705345
  • Zhang B, Lu B-Y, Yu B, et al. Noninvasive prenatal screening for fetal common sex chromosome aneuploidies from maternal blood. J Int Med Res. 2017;45(2):621–630. doi: 10.1177/0300060517695008
  • Porreco RP, Sekedat M, Bombard A, et al. Evaluation of a novel screening method for fetal aneuploidy using cell-free DNA in maternal plasma. J Med Screen. 2020;27(1):1–8. doi: 10.1177/0969141319873682
  • Bianchi DW, Parsa S, Bhatt S, et al. Fetal sex chromosome testing by maternal plasma DNA sequencing clinical laboratory experience and biology. Obstet & Gynecol. 2015;125(2):375–382. doi: 10.1097/AOG.0000000000000637
  • Yin L, Tang Y, Lu Q, et al. Application value of NIPT for uncommon fetal chromosomal abnormalities. Mol Cytogenet. 2020;13(1):13(1. doi: 10.1186/s13039-020-00508-z
  • Liu Y, Liu H, He Y, et al. Clinical performance of non-invasive prenatal served as a first-tier screening test for trisomy 21, 18, 13 and sex chromosome aneuploidy in a pilot city in China. Hum Genomics. 2020;14(1). doi: 10.1186/s40246-020-00268-2
  • Porreco RP, Garite TJ, Maurel K, et al. Noninvasive prenatal screening for fetal trisomies 21, 18, 13 and the common sex chromosome aneuploidies from maternal blood using massively parallel genomic sequencing of DNA. Am J Obstet Gynecol. 2014;211(4):.e365.1–.e365.12. doi: 10.1016/j.ajog.2014.03.042
  • Lefkowitz RB, Tynan JA, Liu T, et al. Clinical validation of a noninvasive prenatal test for genomewide detection of fetal copy number variants. Am J Obstet Gynecol. 2016;215(2):.e227.1–.e227.16. doi: 10.1016/j.ajog.2016.02.030

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.